AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2020
Aug 3, 2020
32939_dirs_2020-08-03_108bc89b-b6bd-45d0-966a-944c6326e814.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-07-31
Reporting Person: Clemmer James C (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-31 | Common Stock | P | 40000 | $8.26 | Acquired | 343319 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.24 to $8.26, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1.
More from ANGIODYNAMICS INC
Legal Proceedings Report
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Board/Management Information
2026
Feb 3
Investor Presentation
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Earnings Release
2026
Jan 6